WF-210 is a potent activator of procaspase-3. It acts by inducing apoptosis in cancer cells and reducing tumor growth in human breast, liver and gallbladder cancer xenografts. References: Wang F, Wang L, Li Y, Wang N, Wang Y, Cao Q, Gong P, Yang J, Wu C. PAC-1 and its derivative WF-210 Inhibit Angiogenesis by inhibiting VEGF/VEGFR pathway. Eur J Pharmacol. 2018 Feb 15;8229-38. doi: 10.1016/j.ejphar.2017.12.035. Epub 2017 Dec 19. PubMed PMID: 29269017.

纯度：≥98%

CAS：1242279-00-0